How Has The Atrial Fibrillation Market Size Evolved In Recent Years?
The atrial fibrillation market has seen considerable growth due to a variety of factors.
• The market size for atrial fibrillation has experienced rapid expansion in the recent past. It is projected to increase from $13.56 billion in 2024 to $15.14 billion in 2025, representing a compound annual growth rate (CAGR) of 11.7%. The growth witnessed during the historical period can be linked to factors such as rising public awareness and screening initiatives, advancements in treatment technology, an upsurge in healthcare expenditure, intensive clinical research and drug innovation, as well as genetic factors.
What Is The Projected Growth Of The Atrial Fibrillation Market?
The Atrial Fibrillation market is expected to maintain its strong growth trajectory in upcoming years.
• The market size for atrial fibrillation is anticipated to experience swift growth in the future years. It's projected to expand to $24.93 billion in 2029 with a compound annual growth rate (CAGR) of 13.3%.
The surge during the forecast years can be linked to a concentration on stroke prevention, programs educating patients and physicians, worldwide initiatives for heart health, an increase in electrophysiology procedures, tailoring of treatment strategies, and governmental efforts for the prevention of cardiovascular diseases. Key trends for the forecast period involve progress in diagnostic technologies, an upswing in atrial fibrillation incidence, advances in catheter ablation methods, the arrival of novel oral anticoagulants (NOACs), integration of wearable tech for monitoring, an expanded role of telemedicine in AF management, and progress in implantable devices.
What Are The Key Drivers Fueling Growth In The Atrial Fibrillation Market?
The proliferation of the elderly population is predicted to fuel the advancement of the atrial fibrillation industry. The elderly demographic, typically adults over the age of 65, are more prone to falls due to several reasons including postural hypotension and balance or ambulation issues. In the majority of elderly patients, indications of age and conduction disruptions are visible on a surface electrocardiogram preceding the onset of AF. For example, in October 2022, the World Health Organization, a United Nations specialized agency based in Switzerland accountable for global public health, forecasted that by 2030, there will be six ageing individuals globally. This signifies that the elderly population will rise to 1.4 billion people from 1 billion in 2020. By 2050, the worldwide number of those aged 60 and older is predicted to reach 2.1 billion, twofold from the present figures. Furthermore, an additional 426 million individuals will be aged 80 or older between 2020 and 2050 compared to current records. As a result, the escalating elderly population is stimulating the enhancement of the atrial fibrillation sector.
What Are The Principal Market Segments In The Global Atrial Fibrillation Industry?
The atrial fibrillation market covered in this report is segmented –
1) By Type: Surgical, Non-Surgical
2) By Technology: Radiofrequency, Laser, Cryotherapy, Other Technologies
3) By Treatment Type: Pharmacological Treatment, Non-pharmacological Treatment, Maze Surgery, Electric Cardioversion
4) By End User: Hospitals, Electrophysiology Labs, Ambulatory Surgical Centers
Subsegments:
1) By Surgical: Catheter Ablation, Maze Procedure, Hybrid Ablation Procedures
2) By Non-Surgical: Antiarrhythmic Drugs, Anticoagulants, Cardioversion Procedures, Device Implants
Pre-Book The Atrial Fibrillation Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
Which Emerging Market Trends Are Altering The Atrial Fibrillation Industry?
Dominant companies in the atrial fibrillation market are introducing cutting-edge products and solutions such as patient-based clinical decision support tools to solidify their footprint in the market. Clinical decision support tools (CDSTs) are either electronic systems or software developed to help healthcare professionals make timely and informed decisions concerning patient care. These tools are designed to incorporate significant clinical information from different sources. For instance, in August 2023, GE HealthCare, an American multinational medical technology firm, unveiled CardioVisio. It is a patient-focused clinical decision support tool designed to aid physicians in making evidence-backed clinical decisions driven by current atrial fibrillation guidelines, and to visualize longitudinal data from assorted data sources that is pertinent to illness progression. CardioVisio for atrial fibrillation can help cardiologists to streamline clinician image interpretation, providing a comprehensive view of the patient's cardiac history and healthcare journey, including past diagnoses, prescribed medications, interventions, and comorbidities.
Who Are the Key Players In The Atrial Fibrillation Market?
Major companies operating in the atrial fibrillation market include:
• AtriCure Inc.
• Johnson & Johnson Private Limited
• Abbott Laboratories
• C.H. Boehringer Sohn AG & Co. KG
• Biotronik Se & Co. Kg
• Boston Scientific Corporation
• Bristol-Myers Squibb Company
• CardioFocus Inc.
• Sanofi S.A
• Medtronic PLC
• Biosense Webster Inc.
• MicroPort Scientific Corporation
• Siemens AG
• Acutus Medical Inc.
• AEGEA Medical Inc.
• Apama Medical Inc.
• Aria CV Inc.
• Armetheon Inc.
• BioSig Technologies Inc.
• Cardialen Inc.
• CardioRobotics Inc.
• CardioInsight Technologies Inc.
• Circa Scientific LLC
• CorWave SA
• EpiEP Inc.
• Farapulse Inc.
• Fibralign Corporation
• Impulse Dynamics NV
• JenaValve Technology Inc.
• Kardium Inc.
What Are The Regional Insights Into The Atrial Fibrillation Market?
North America was the largest region in the atrial fibrillation market in 2024. Asia-Pacific is expected to be the fastest-growing region in the atrial fibrillation market report forecast period. The regions covered in the atrial fibrillation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
